In the ongoing search for new cancer treatments, scientists rely on robust preclinical models to evaluate drug efficacy before advancing to human clinical trials. Among the most widely used and essential tools is the tumor xenograft model, which creates a "miniature battlefield" inside mice to closely mimic human tumor growth and therapy response.
What is a CDX Model?
The Cell Line-Derived Xenograft (CDX) model is a foundational in vivo system in cancer research. This xenograft model involves implanting established human cancer cell lines into immunodeficient mice—mice that lack a functional immune system to prevent rejection of human cells. The resulting tumors provide a reproducible testing platform for assessing how well anti-cancer drug candidates inhibit tumor growth.
Key Advantages of CDX Models in Drug Development
CDX models remain a gold standard in preclinical cancer research for several reasons:
-
Easy Tumor Monitoring: Tumors typically grow subcutaneously, enabling straightforward measurement of tumor size and direct observation of treatment effects.
-
Rapid Results: The fast proliferation rate of cancer cells allows for quick assessment of drug efficacy, accelerating the early drug discovery pipeline.
-
Cost-Effective Research: Compared to more complex patient-derived xenograft (PDX) models, CDX models are relatively affordable and easier to establish and scale.
Two Major Types of In Vivo Tumor Models
There are two primary in vivo tumor models used in oncology studies, each serving distinct purposes in cancer drug development:
1. The Human-Mouse Model: CDX (Xenograft) Model
-
-
How It’s Created: Human cancer cells are transplanted into immunodeficient mice.
-
Research Applications: This xenograft model is widely used for screening a broad range of cancer therapeutics, including chemotherapy drugs, targeted therapies, and novel small molecules. Its main strength lies in using human-derived tumor cells, making it highly relevant for studying drug effects on human cancer biology in a living system.
-
2. The Mouse-Mouse Model: Allograft Model
-
-
How It’s Created: Mouse tumor cells are implanted into immunocompetent mice with the same genetic background.
-
Research Applications: This allograft model is specially designed for immuno-oncology research. Because the host mice have an intact immune system, this model is ideal for evaluating immunotherapy drugs—treatments designed to stimulate the immune system to attack cancer cells.
-
Conclusion: The Role of CDX and Allograft Models in Advancing Cancer Therapy
Tumor xenograft models, including both CDX models and allograft models, offer powerful and complementary approaches in preclinical cancer research. By enabling the study of human tumor growth and drug response in a controlled yet biologically relevant environment, these models provide critical insights that help prioritize the most promising drug candidates for clinical trials. Their continued use is essential for accelerating the development of new, effective cancer treatments.
